Avinger Inc. (NASDAQ:AVGR) reached a new 52-week low on Thursday . The stock traded as low as $3.65 and last traded at $3.79, with a volume of 1,989,446 shares traded. The stock had previously closed at $4.62.

Several research firms recently weighed in on AVGR. Zacks Investment Research upgraded Avinger from a “sell” rating to a “hold” rating in a report on Friday, July 1st. BTIG Research reiterated a “buy” rating and set a $18.00 price target on shares of Avinger in a report on Friday, July 15th. Finally, Canaccord Genuity reiterated a “buy” rating on shares of Avinger in a report on Tuesday, July 12th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $18.75.

The company has a 50-day moving average price of $7.92 and a 200 day moving average price of $11.12. The firm’s market capitalization is $48.16 million.

Avinger (NASDAQ:AVGR) last posted its quarterly earnings data on Monday, August 1st. The medical device company reported ($1.06) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($1.15) by $0.09. The firm had revenue of $4.70 million for the quarter, compared to the consensus estimate of $3.05 million. Equities research analysts anticipate that Avinger Inc. will post ($4.36) EPS for the current year.

Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.